These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38683377)

  • 1. Tyrosine kinase 2 modulates splenic B cells through type I IFN and TLR7 signaling.
    Bodega-Mayor I; Delgado-Wicke P; Arrabal A; Alegría-Carrasco E; Nicolao-Gómez A; Jaén-Castaño M; Espadas C; Dopazo A; de Luis EV; Martín-Gayo E; Gaspar ML; de Andrés B; Fernández-Ruiz E
    Cell Mol Life Sci; 2024 Apr; 81(1):199. PubMed ID: 38683377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 7-mediated type I interferon signaling prevents cholestasis- and hepatotoxin-induced liver fibrosis.
    Roh YS; Park S; Kim JW; Lim CW; Seki E; Kim B
    Hepatology; 2014 Jul; 60(1):237-49. PubMed ID: 24375615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
    Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
    Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of TLR7 promotes cell-intrinsic expansion and autoantibody production by transitional T1 B cells.
    Giltiay NV; Chappell CP; Sun X; Kolhatkar N; Teal TH; Wiedeman AE; Kim J; Tanaka L; Buechler MB; Hamerman JA; Imanishi-Kari T; Clark EA; Elkon KB
    J Exp Med; 2013 Nov; 210(12):2773-89. PubMed ID: 24145511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BANK1 Regulates IgG Production in a Lupus Model by Controlling TLR7-Dependent STAT1 Activation.
    Wu YY; Kumar R; Iida R; Bagavant H; Alarcón-Riquelme ME
    PLoS One; 2016; 11(5):e0156302. PubMed ID: 27228057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2.
    Piganis RA; De Weerd NA; Gould JA; Schindler CW; Mansell A; Nicholson SE; Hertzog PJ
    J Biol Chem; 2011 Sep; 286(39):33811-8. PubMed ID: 21757742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of TLR7 gene expression mediating NF-κB signaling pathway on the pathogenesis of bronchial asthma in mice and the intervention role of IFN-γ.
    Song L; Luan B; Xu QR; Wang XF
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):866-879. PubMed ID: 33577041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ-specific and differential requirement of TYK2 and IFNAR1 for LPS-induced iNOS expression in vivo.
    Painz R; Walter I; Kolbe T; Rigler D; Vogl C; Steinborn R; Rülicke T; Helmreich M; Karaghiosoff M; Müller M
    Immunobiology; 2007; 212(9-10):863-75. PubMed ID: 18086385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
    Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
    Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.
    Gautier G; Humbert M; Deauvieau F; Scuiller M; Hiscott J; Bates EE; Trinchieri G; Caux C; Garrone P
    J Exp Med; 2005 May; 201(9):1435-46. PubMed ID: 15851485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.
    Rip J; de Bruijn MJW; Appelman MK; Pal Singh S; Hendriks RW; Corneth OBJ
    Front Immunol; 2019; 10():95. PubMed ID: 30761150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine kinase 2 promotes sepsis-associated lethality by facilitating production of interleukin-27.
    Bosmann M; Strobl B; Kichler N; Rigler D; Grailer JJ; Pache F; Murray PJ; Müller M; Ward PA
    J Leukoc Biol; 2014 Jul; 96(1):123-31. PubMed ID: 24604832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses.
    Fink K; Lang KS; Manjarrez-Orduno N; Junt T; Senn BM; Holdener M; Akira S; Zinkernagel RM; Hengartner H
    Eur J Immunol; 2006 Aug; 36(8):2094-105. PubMed ID: 16810635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RP105/MD-1 complex is indispensable for TLR4/MD-2-dependent proliferation and IgM-secreting plasma cell differentiation of marginal zone B cells.
    Nagai Y; Yanagibashi T; Watanabe Y; Ikutani M; Kariyone A; Ohta S; Hirai Y; Kimoto M; Miyake K; Takatsu K
    Int Immunol; 2012 Jun; 24(6):389-400. PubMed ID: 22354914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type II but Not Type I IFN Signaling Is Indispensable for TLR7-Promoted Development of Autoreactive B Cells and Systemic Autoimmunity.
    Chodisetti SB; Fike AJ; Domeier PP; Singh H; Choi NM; Corradetti C; Kawasawa YI; Cooper TK; Caricchio R; Rahman ZSM
    J Immunol; 2020 Feb; 204(4):796-809. PubMed ID: 31900342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 7 controls the anti-retroviral germinal center response.
    Browne EP
    PLoS Pathog; 2011 Oct; 7(10):e1002293. PubMed ID: 21998589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell intrinsic TLR7 signals promote depletion of the marginal zone in a murine model of Wiskott-Aldrich syndrome.
    Kolhatkar NS; Scharping NE; Sullivan JM; Jacobs HM; Schwartz MA; Khim S; Notarangelo LD; Thrasher AJ; Rawlings DJ; Jackson SW
    Eur J Immunol; 2015 Oct; 45(10):2773-9. PubMed ID: 26256668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B Cell-intrinsic TLR7 signaling is required for optimal B cell responses during chronic viral infection.
    Clingan JM; Matloubian M
    J Immunol; 2013 Jul; 191(2):810-8. PubMed ID: 23761632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The
    Gorman JA; Hundhausen C; Kinsman M; Arkatkar T; Allenspach EJ; Clough C; West SE; Thomas K; Eken A; Khim S; Hale M; Oukka M; Jackson SW; Cerosaletti K; Buckner JH; Rawlings DJ
    Front Immunol; 2019; 10():44. PubMed ID: 30740104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
    Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
    J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.